Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET

Open access
Komajda, Michel, Anker, Stefan D., Charlesworth, Andrew, Okonko, Darlington, Metra, Marco, Di Lenarda, Andrea, Remme, Willem, Moullet, Christine, Swedberg, Karl, Cleland, John G.F., Poole-Wilson, Philip A. · 2006 · European Heart Journal

Abstract

AIMS: Anaemia is a common comorbidity in chronic heart failure (CHF). The predictors of new onset anaemia (NOA) and its long-term prognostic value, particularly in patients treated with beta-blockers, are not known. METHODS AND RESULTS: In COMET, 3029 patients with CHF in NYHA II-IV and EF <35% were randomized to carvedilol or metoprolol tartrate and were followed for an average of 58 months. Plasma haemoglobin (Hb) concentrations were measured at a central laboratory at randomization, at four monthly intervals for the first year and annually thereafter. According to WHO criteria, anaemia was defined when Hb measured <13 g/dL for men and <12 g/dL for women. We considered anaemia to be severe when Hb <11.5 g/dL for men and <10.5 g/dL for women. The baseline mean Hb was 14.2 +/- 1.5 g/dL (n = 2996) and 15.9% of patients had anaemia (males, 16.0%; females, 15.2%). At baseline, severe anaemia was found in 3.3% of patients (males, 3.6%; females, 2.0%). During the study, all-cause mortality (RR 1.47) death or hospitalization (RR 1.28), and heart failure hospitalization (RR 1.43, all P < 0.0001) were higher in anaemic when compared with non-anaemic patients. In patients without anaemia at baseline, at the end of the study, the cumulative frequency of NOA was 28.1% in males and 27.0% in females. NOA increased over time from 14.2% at year 1 to 27.5% at year 5. Predictors of NOA were: higher age, diuretic dose, creatinine (all P < 0.0001), higher serum potassium, lower serum sodium, body mass index, and use of aldosterone antagonists, carvedilol, and digitalis (all P < 0.03). Treatment with carvedilol (vs. metoprolol tartrate) was associated with a 24% increased risk to develop NOA (P = 0.0047), but not severe anaemia (P = 0.18). Patients with a Hb decrease of >3 g/dL (RR 3.37, P < 0.0001) or of 2.0-3.0 g/dL (RR 1.47, P = 0.011) from baseline had an increased subsequent mortality when compared with patients having Hb increases of 0-1.0 g/dL. CONCLUSION: In stable ambulatory CHF patients, development of NOA is frequent and can be predicted by a set of clinical variables. Decreases in Hb over time relate to future increased morbidity and mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehl012

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 14

  1. 2003, Effect of anemia on exercise tolerance in chronic heart failure in men, Am J Cardiol, 91, 888, 10.1016/S0002-9149(03)00030-4 · DOI
  2. 2005, Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT, Circulation, 112, 1121, 10.1161/CIRCULATIONAHA.104.512988 · DOI · Paper page
  3. 2004, Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial, Eur Heart J, 25, 1021, 10.1016/j.ehj.2004.04.023 · DOI · Paper page
  4. 2004, Anemia and its relationship to clinical outcome in heart failure, Circulation, 110, 149, 10.1161/01.CIR.0000134279.79571.73 · DOI · Paper page
  5. 2004, Prevalence of anemia in patients with chronic heart failure and their clinical characteristics, J Card Fail, 10, S1, 10.1016/j.cardfail.2004.01.003 · DOI
  6. 2003, Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 · DOI · Paper page
  7. 2005, Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure, Eur Heart J, 26, 2232, 10.1093/eurheartj/ehi388 · DOI · Paper page
  8. 2005, Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction, J Am Coll Cardiol, 3, 391
  9. 2004, Anemia in chronic heart failure: pathogenetic mechanisms, J Card Fail, 10, S5, 10.1016/j.cardfail.2004.01.004 · DOI
  10. 2000, Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice, J Clin Invest, 106, 1391, 10.1172/JCI10557 · DOI · Paper page
  11. 1976, The beta-adrenergic receptor and adenylate cyclase, Biochimi Biophys Acta, 457, 1, 10.1016/0304-4157(76)90012-5 · DOI
  12. 1966, The effect of central nervous system stimulation on erythropoiesis in rats with chronically implanted electrodes, J Lab Clin MedI, 67, 713
  13. 1979, Influence of albuterol on erythropoïetin production and erythroid progenitor cell activation, Am J Physiol, 236, H422
  14. 1984, Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man, Br J Haematol, 56, 323, 10.1111/j.1365-2141.1984.tb03959.x · DOI

Cited by

See all 226

Metadata

Authors
Komajda, M., Anker, S. D., Charlesworth, A., Okonko, D., Metra, M., Di Lenarda, A., Remme, W., Moullet, C., Swedberg, K., Cleland, J. G. F., & Poole-Wilson, P. A.
Venue
European Heart Journal
Published
2006-05-22
Volume
27
Issue
12
Pages
1440-1446
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2161097402
Cited by
226
References
4
FWCI
10.63
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. https://app.cochat.ai/papers/10.1093/eurheartj/ehl012
The paper
Komajda, M., Anker, S. D., Charlesworth, A., Okonko, D., Metra, M., Di Lenarda, A., Remme, W., Moullet, C., Swedberg, K., Cleland, J. G. F., & Poole-Wilson, P. A. (2006). The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. European Heart Journal. https://doi.org/10.1093/eurheartj/ehl012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.